Chang YC - Search Results

1

Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab).

Ng CY, Tzeng IS, Liu SH, Chang YC, Huang YH. Ng CY, et al. Among authors: chang yc. J Dermatol. 2018 Mar;45(3):309-313. doi: 10.1111/1346-8138.14079. Epub 2017 Oct 5. J Dermatol. 2018. Retraction in: J Dermatol. 2018 Aug;45(8):1026. doi: 10.1111/1346-8138.14520 PMID: 28980716 Retracted.

2

Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis.

Lin YK, Chang CJ, Chang YC, Wong WR, Chang SC, Pang JH. Lin YK, et al. Among authors: chang sc, chang yc, chang cj. Arch Dermatol. 2008 Nov;144(11):1457-64. doi: 10.1001/archderm.144.11.1457. Arch Dermatol. 2008. PMID: 19015420 Clinical Trial.

3

Treatment of psoriatic nails with indigo naturalis oil extract: a non-controlled pilot study.

Lin YK, See LC, Chang YC, Huang YH, Chen JL, Tsou TC, Leu YL, Shen YM. Lin YK, et al. Among authors: chang yc. Dermatology. 2011;223(3):239-43. doi: 10.1159/000333362. Epub 2011 Nov 3. Dermatology. 2011. PMID: 22056841 Clinical Trial.

4

Comparison of refined and crude indigo naturalis ointment in treating psoriasis: randomized, observer-blind, controlled, intrapatient trial.

Lin YK, See LC, Huang YH, Chang YC, Tsou TC, Leu YL, Shen YM. Lin YK, et al. Among authors: chang yc. Arch Dermatol. 2012 Mar;148(3):397-400. doi: 10.1001/archdermatol.2011.1091. Arch Dermatol. 2012. PMID: 22431789 Clinical Trial. No abstract available.

5

Efficacy and safety of Indigo naturalis extract in oil (Lindioil) in treating nail psoriasis: a randomized, observer-blind, vehicle-controlled trial.

Lin YK, See LC, Huang YH, Chang YC, Tsou TC, Lin TY, Lin NL. Lin YK, et al. Among authors: chang yc. Phytomedicine. 2014 Jun 15;21(7):1015-20. doi: 10.1016/j.phymed.2014.02.013. Epub 2014 Mar 26. Phytomedicine. 2014. PMID: 24680615 Clinical Trial.

6

The (CCTTT) n pentanucleotide repeat polymorphism in the inducible nitric oxide synthase gene promoter and the risk of psoriasis in Taiwanese.

Chang YC, Wu WM, Huang YH, Chung WH, Tsai HY, Hsu LA. Chang YC, et al. Arch Dermatol Res. 2015 Jul;307(5):425-32. doi: 10.1007/s00403-015-1542-6. Epub 2015 Feb 8. Arch Dermatol Res. 2015. PMID: 25663087

7

A Chinese Herb, Indigo Naturalis, Extracted in Oil (Lindioil) Used Topically to Treat Psoriatic Nails: A Randomized Clinical Trial.

Lin YK, Chang YC, Hui RC, See LC, Chang CJ, Yang CH, Huang YH. Lin YK, et al. Among authors: chang yc, chang cj. JAMA Dermatol. 2015 Jun;151(6):672-4. doi: 10.1001/jamadermatol.2014.5460. JAMA Dermatol. 2015. PMID: 25738921 Clinical Trial. No abstract available.

8

Impact of the HLA-B(*)58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions.

Ng CY, Yeh YT, Wang CW, Hung SI, Yang CH, Chang YC, Chang WC, Lin YJ, Chang CJ, Su SC, Fan WL, Chen DY, Wu YJ, Tian YC, Hui RC, Chung WH; Taiwan Severe Cutaneous Adverse Reaction Consortium. Ng CY, et al. Among authors: chang wc, chang yc, chang cj. J Invest Dermatol. 2016 Jul;136(7):1373-1381. doi: 10.1016/j.jid.2016.02.808. Epub 2016 Mar 18. J Invest Dermatol. 2016. PMID: 26996548 Free article.

9

Characteristics of Decreased Pulmonary Function and Clinical Symptoms in Nickel Electroplating Workers.

Tsao YC, Chang YC, Gu PW, Tzeng IS, Luo JJ. Tsao YC, et al. Among authors: chang yc. J Occup Environ Med. 2018 Apr;60(4):337-342. doi: 10.1097/JOM.0000000000001204. J Occup Environ Med. 2018. PMID: 29065059

10

The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label.

Wang YH, Chen CB, Tassaneeyakul W, Saito Y, Aihara M, Choon SE, Lee HY, Chang MM, Roa FD, Wu CW, Zhang J, Nakkam N, Konyoung P, Okamoto-Uchida Y, Cheung CM, Huang JW, Ji C, Cheng B, Hui RC, Chu CY, Chen YJ, Wu CY, Hsu CK, Chiu TM, Huang YH, Lu CW, Yang CY, Lin YT, Chi MH, Ho HC, Lin JY, Yang CH, Chang YC, Su SC, Wang CW, Fan WL, Hung SI, Chung WH; Asian Severe Cutaneous Adverse Reaction Consortium. Wang YH, et al. Among authors: chang mm, chang yc. Clin Pharmacol Ther. 2019 Jan;105(1):112-120. doi: 10.1002/cpt.1071. Epub 2018 Aug 9. Clin Pharmacol Ther. 2019. PMID: 29569740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,345 results

Search Page

Filters